Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04RKH
|
||||
Former ID |
DIB010352
|
||||
Drug Name |
APH-0911
|
||||
Synonyms |
Docetaxel prodrug (oral nanoparticle formulation), Aphios; Paclitaxel prodrug (oral formulation), Aphios; Docetaxel prodrug (water-soluble), Aphios; Paclitaxel prodrug (water-soluble), Aphios; 10alpha-GAG-docetaxel
|
||||
Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Investigative | [543674] | ||
Company |
Aphios Corp
|
||||
Target and Pathway | |||||
Target(s) | Tubulin beta | Target Info | Modulator | [543674] | |
PANTHER Pathway | Cytoskeletal regulation by Rho GTPase | ||||
Huntington disease | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.